2014-2026 Global Cancer Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID :Maia-14769650 | Published Date: 12-Dec-2019 | No. of pages: 111Description
TOC
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2014-2026)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Cancer Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Cancer Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Cancer Drugs Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Cancer Drugs Market-Segmentation by Type
5.1 Breast Cancer
5.2 Blood Cancer
5.3 Gastrointestinal Cancer
5.4 Prostate Cancer
5.5 Skin Cancer
5.6 Lung Cancer
6 Global Cancer Drugs Market-Segmentation by Application
6.1 Immunotherapy
6.2 Targeted Therapy
6.3 Chemotherapy
6.4 Hormone Therapy
7 Global Cancer Drugs Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence – Company Profiles
8.1 Merck
8.1.1 Merck Profile
8.1.2 Merck Sales, Growth Rate and Global Market Share from 2014-2019E
8.1.3 Merck Product/Solution Launches and Enhancements Analysis
8.1.4 Merck Business Overview/Recent Development/Acquisitions
8.2 Bristol-Myers Squibb
8.2.1 Bristol-Myers Squibb Profile
8.2.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2014-2019E
8.2.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
8.2.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.3 Teva Pharmaceuticals
8.3.1 Teva Pharmaceuticals Profile
8.3.2 Teva Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E
8.3.3 Teva Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.3.4 Teva Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.4 Boehringer Ingelheim
8.4.1 Boehringer Ingelheim Profile
8.4.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2014-2019E
8.4.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
8.4.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.5 Celgene Corporation
8.5.1 Celgene Corporation Profile
8.5.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2014-2019E
8.5.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis
8.5.4 Celgene Corporation Business Overview/Recent Development/Acquisitions
8.6 Ariad Pharmaceuticals
8.6.1 Ariad Pharmaceuticals Profile
8.6.2 Ariad Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E
8.6.3 Ariad Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.6.4 Ariad Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.7 Novartis
8.7.1 Novartis Profile
8.7.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E
8.7.3 Novartis Product/Solution Launches and Enhancements Analysis
8.7.4 Novartis Business Overview/Recent Development/Acquisitions
8.8 Eli Lilly
8.8.1 Eli Lilly Profile
8.8.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2014-2019E
8.8.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
8.8.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.9 Bayer
8.9.1 Bayer Profile
8.9.2 Bayer Sales, Growth Rate and Global Market Share from 2014-2019E
8.9.3 Bayer Product/Solution Launches and Enhancements Analysis
8.9.4 Bayer Business Overview/Recent Development/Acquisitions
8.10 Sanofi and Pfizer
8.10.1 Sanofi and Pfizer Profile
8.10.2 Sanofi and Pfizer Sales, Growth Rate and Global Market Share from 2014-2019E
8.10.3 Sanofi and Pfizer Product/Solution Launches and Enhancements Analysis
8.10.4 Sanofi and Pfizer Business Overview/Recent Development/Acquisitions
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Profile
8.11.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2014-2019E
8.11.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.11.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.12 Amgen
8.12.1 Amgen Profile
8.12.2 Amgen Sales, Growth Rate and Global Market Share from 2014-2019E
8.12.3 Amgen Product/Solution Launches and Enhancements Analysis
8.12.4 Amgen Business Overview/Recent Development/Acquisitions
8.13 Johnson and Johnson
8.13.1 Johnson and Johnson Profile
8.13.2 Johnson and Johnson Sales, Growth Rate and Global Market Share from 2014-2019E
8.13.3 Johnson and Johnson Product/Solution Launches and Enhancements Analysis
8.13.4 Johnson and Johnson Business Overview/Recent Development/Acquisitions
8.14 Hoffmann-La Roche
8.14.1 Hoffmann-La Roche Profile
8.14.2 Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2014-2019E
8.14.3 Hoffmann-La Roche Product/Solution Launches and Enhancements Analysis
8.14.4 Hoffmann-La Roche Business Overview/Recent Development/Acquisitions
9 Global Cancer Drugs Market-Segmentation by Geography
10 North America
10.1 North America Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
10.2 North America Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
10.3 North America Cancer Drugs Production Analysis from 2014-2019E
10.4 North America Cancer Drugs Consumption Analysis from 2014-2019E
10.5 North America Cancer Drugs Import and Export from 2014-2019E
10.6 North America Cancer Drugs Value, Production and Market Share by Type (2014-2019E)
10.7 North America Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E)
10.8 North America Cancer Drugs by Country (United States, Canada)
10.8.1 North America Cancer Drugs Sales by Country (2014-2019E)
10.8.2 North America Cancer Drugs Consumption Value by Country (2014-2019E)
10.9 North America Cancer Drugs Market PEST Analysis
11 Europe
11.1 Europe Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
11.2 Europe Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
11.3 Europe Cancer Drugs Production Analysis from 2014-2019E
11.4 Europe Cancer Drugs Consumption Analysis from 2014-2019E
11.5 Europe Cancer Drugs Import and Export from 2014-2019E
11.6 Europe Cancer Drugs Value, Production and Market Share by Type (2014-2019E)
11.7 Europe Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E)
11.8 Europe Cancer Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Cancer Drugs Sales by Country (2014-2019E)
11.8.2 Europe Cancer Drugs Consumption Value by Country (2014-2019E)
11.9 Europe Cancer Drugs Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
12.2 Asia-Pacific Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
12.3 Asia-Pacific Cancer Drugs Production Analysis from 2014-2019E
12.4 Asia-Pacific Cancer Drugs Consumption Analysis from 2014-2019E
12.5 Asia-Pacific Cancer Drugs Import and Export from 2014-2019E
12.6 Asia-Pacific Cancer Drugs Value, Production and Market Share by Type (2014-2019E)
12.7 Asia-Pacific Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E)
12.8 Asia-Pacific Cancer Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Cancer Drugs Sales by Country (2014-2019E)
12.8.2 Asia-Pacific Cancer Drugs Consumption Value by Country (2014-2019E)
12.9 Asia-Pacific Cancer Drugs Market PEST Analysis
13 Latin America
13.1 Latin America Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
13.2 Latin America Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
13.3 Latin America Cancer Drugs Production Analysis from 2014-2019E
13.4 Latin America Cancer Drugs Consumption Analysis from 2014-2019E
13.5 Latin America Cancer Drugs Import and Export from 2014-2019E
13.6 Latin America Cancer Drugs Value, Production and Market Share by Type (2014-2019E)
13.7 Latin America Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E)
13.8 Latin America Cancer Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Cancer Drugs Sales by Country (2014-2019E)
13.8.2 Latin America Cancer Drugs Consumption Value by Country (2014-2019E)
13.9 Latin America Cancer Drugs Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
14.2 Middle East & Africa Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
14.3 Middle East & Africa Cancer Drugs Production Analysis from 2014-2019E
14.4 Middle East & Africa Cancer Drugs Consumption Analysis from 2014-2019E
14.5 Middle East & Africa Cancer Drugs Import and Export from 2014-2019E
14.6 Middle East & Africa Cancer Drugs Value, Production and Market Share by Type (2014-2019E)
14.7 Middle East & Africa Cancer Drugs Consumption, Value and Market Share by Application (2014-2019E)
14.8 Middle East & Africa Cancer Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Cancer Drugs Sales by Country (2014-2019E)
14.8.2 Middle East & Africa Cancer Drugs Consumption Value by Country (2014-2019E)
14.9 Middle East & Africa Cancer Drugs Market PEST Analysis
15 Future Forecast of the Global Cancer Drugs Market from 2018-2026
15.1 Future Forecast of the Global Cancer Drugs Market from 2019-2026 Segment by Region
15.2 Global Cancer Drugs Production and Growth Rate Forecast by Type (2019-2026)
15.3 Global Cancer Drugs Consumption and Growth Rate Forecast by Application (2019-2026)
16 Appendix
16.1 Methodology
16.2 Research Data Source
Tables & Figures
List of Tables and Figures
Global Cancer Drugs Market Value ($) and Growth Rate of Cancer Drugs from 2014-2026
Global Cancer Drugs Production and Growth Rate Segment by Product Type from 2014-2026F
Global Cancer Drugs Consumption and Growth Rate Segment by Application from 2014-2019E
Figure Cancer Drugs Picture
Table Product Specifications of Cancer Drugs
Table Driving Factors for this Market
Table Industry News of Cancer Drugs Market
Figure Value Chain Status of Cancer Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Cancer Drugs Production and Growth Rate Segment by Product Type from 2014-2019E
Table Global Cancer Drugs Value ($) and Growth Rate Segment by Product Type from 2014-2019E
Figure Breast Cancer of Cancer Drugs
Figure Blood Cancer of Cancer Drugs
Figure Gastrointestinal Cancer of Cancer Drugs
Figure Prostate Cancer of Cancer Drugs
Figure Skin Cancer of Cancer Drugs
Figure Lung Cancer of Cancer Drugs
Table Global Cancer Drugs Consumption and Growth Rate Segment by Application from 2014-2019E
Table Global Cancer Drugs Value ($) and Growth Rate Segment by Application from 2014-2019E
Figure Immunotherapy of Cancer Drugs
Figure Targeted Therapy of Cancer Drugs
Figure Chemotherapy of Cancer Drugs
Figure Hormone Therapy of Cancer Drugs
Table Global Cancer Drugs Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E
Table Global Cancer Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E
Figure Traditional Marketing Channel (Offline) of Cancer Drugs
Figure Online Channel of Cancer Drugs
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2014-2019E
Figure Merck Revenue ($) and Global Market Share from 2014-2019E
Table Merck Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2014-2019E
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2014-2019E
Table Bristol-Myers Squibb Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Teva Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva Pharmaceuticals Sales and Growth Rate from 2014-2019E
Figure Teva Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E
Table Teva Pharmaceuticals Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2014-2019E
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2014-2019E
Table Boehringer Ingelheim Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Celgene Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Celgene Corporation Sales and Growth Rate from 2014-2019E
Figure Celgene Corporation Revenue ($) and Global Market Share from 2014-2019E
Table Celgene Corporation Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Ariad Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Ariad Pharmaceuticals Sales and Growth Rate from 2014-2019E
Figure Ariad Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E
Table Ariad Pharmaceuticals Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2014-2019E
Figure Novartis Revenue ($) and Global Market Share from 2014-2019E
Table Novartis Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2014-2019E
Figure Eli Lilly Revenue ($) and Global Market Share from 2014-2019E
Table Eli Lilly Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2014-2019E
Figure Bayer Revenue ($) and Global Market Share from 2014-2019E
Table Bayer Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Sanofi and Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi and Pfizer Sales and Growth Rate from 2014-2019E
Figure Sanofi and Pfizer Revenue ($) and Global Market Share from 2014-2019E
Table Sanofi and Pfizer Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2014-2019E
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2014-2019E
Table GlaxoSmithKline Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Amgen Profile (Company Name, Plants Distribution, Sales Region)
Figure Amgen Sales and Growth Rate from 2014-2019E
Figure Amgen Revenue ($) and Global Market Share from 2014-2019E
Table Amgen Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Johnson and Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson and Johnson Sales and Growth Rate from 2014-2019E
Figure Johnson and Johnson Revenue ($) and Global Market Share from 2014-2019E
Table Johnson and Johnson Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Hoffmann-La Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Hoffmann-La Roche Sales and Growth Rate from 2014-2019E
Figure Hoffmann-La Roche Revenue ($) and Global Market Share from 2014-2019E
Table Hoffmann-La Roche Cancer Drugs Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Global Cancer Drugs Production Value ($) by Region from 2014-2019E
Table Global Cancer Drugs Production Value Share by Region from 2014-2019E
Table Global Cancer Drugs Production by Region from 2014-2019E
Table Global Cancer Drugs Consumption Value ($) by Region from 2014-2019E
Table Global Cancer Drugs Consumption by Region from 2014-2019E
Table North America Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table North America Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table North America Cancer Drugs Import and Export from 2014-2019E
Table North America Cancer Drugs Value ($) by Type (2014-2019E)
Table North America Cancer Drugs Production by Type (2014-2019E)
Table North America Cancer Drugs Consumption by Application (2014-2019E)
Table North America Cancer Drugs Consumption by Country (2014-2019E)
Table North America Cancer Drugs Consumption Value ($) by Country (2014-2019E)
Figure North America Cancer Drugs Market PEST Analysis
Table Europe Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Europe Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Europe Cancer Drugs Import and Export from 2014-2019E
Table Europe Cancer Drugs Value ($) by Type (2014-2019E)
Table Europe Cancer Drugs Production by Type (2014-2019E)
Table Europe Cancer Drugs Consumption by Application (2014-2019E)
Table Europe Cancer Drugs Consumption by Country (2014-2019E)
Table Europe Cancer Drugs Consumption Value ($) by Country (2014-2019E)
Figure Europe Cancer Drugs Market PEST Analysis
Table Asia-Pacific Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Asia-Pacific Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Asia-Pacific Cancer Drugs Import and Export from 2014-2019E
Table Asia-Pacific Cancer Drugs Value ($) by Type (2014-2019E)
Table Asia-Pacific Cancer Drugs Production by Type (2014-2019E)
Table Asia-Pacific Cancer Drugs Consumption by Application (2014-2019E)
Table Asia-Pacific Cancer Drugs Consumption by Country (2014-2019E)
Table Asia-Pacific Cancer Drugs Consumption Value ($) by Country (2014-2019E)
Figure Asia-Pacific Cancer Drugs Market PEST Analysis
Table Latin America Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Latin America Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Latin America Cancer Drugs Import and Export from 2014-2019E
Table Latin America Cancer Drugs Value ($) by Type (2014-2019E)
Table Latin America Cancer Drugs Production by Type (2014-2019E)
Table Latin America Cancer Drugs Consumption by Application (2014-2019E)
Table Latin America Cancer Drugs Consumption by Country (2014-2019E)
Table Latin America Cancer Drugs Consumption Value ($) by Country (2014-2019E)
Figure Latin America Cancer Drugs Market PEST Analysis
Table Middle East & Africa Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Middle East & Africa Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Middle East & Africa Cancer Drugs Import and Export from 2014-2019E
Table Middle East & Africa Cancer Drugs Value ($) by Type (2014-2019E)
Table Middle East & Africa Cancer Drugs Production by Type (2014-2019E)
Table Middle East & Africa Cancer Drugs Consumption by Application (2014-2019E)
Table Middle East & Africa Cancer Drugs Consumption by Country (2014-2019E)
Table Middle East & Africa Cancer Drugs Consumption Value ($) by Country (2014-2019E)
Figure Middle East & Africa Cancer Drugs Market PEST Analysis
Table Global Cancer Drugs Value ($) and Growth Rate Forecast by Region (2018-2026)
Table Global Cancer Drugs Production and Growth Rate Forecast by Region (2019-2026)
Table Global Cancer Drugs Consumption and Growth Rate Forecast by Region (2019-2026)
Table Global Cancer Drugs Production and Growth Rate Forecast by Type (2019-2026)
Table Global Cancer Drugs Consumption and Growth Rate Forecast by Application (2019-2026)
Companies
- PRICE
-
$3460$5000